e-learning
resources
London 2016
Wednesday, 07.09.2016
Connective tissue disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease?
Hanna Nurmi (Kuopio, Finland), Hanna Nurmi, Minna Purokivi, Miia Kärkkäinen, Hannu-Pekka Kettunen, Tuomas Selander, Riitta Kaarteenaho
Source:
International Congress 2016 – Connective tissue disorders
Session:
Connective tissue disorders
Session type:
Poster Discussion
Number:
4885
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hanna Nurmi (Kuopio, Finland), Hanna Nurmi, Minna Purokivi, Miia Kärkkäinen, Hannu-Pekka Kettunen, Tuomas Selander, Riitta Kaarteenaho. Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease?. Eur Respir J 2016; 48: Suppl. 60, 4885
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Related content which might interest you:
Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
Source: Breathe, 16 (4) 200223; 10.1183/20734735.0223-2020
Year: 2020
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Characteristics and predictors of outcome in rheumatoid arthritis related ILD
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Nintedanib reduces fibrotic markers in the lung in a model of rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018
Year: 2019
Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Pragmatic prognostic approach of rheumatoid arthritis-associated interstitial lung disease
Source: Eur Respir J 2010; 35: 1206-1208
Year: 2010
Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
A prognostic staging system for rheumatoid arthritis-associated interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020
Year: 2021
Automated quantification system predict a progressive phenotype in rheumatoid arthritis-associated interstitial lung disease
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021
The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA)
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014
Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
Source: Eur Respir J 2016; 47: 588-596
Year: 2016
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Predicting progression of RA-ILD using anti-CCP
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Interstitial lung disease in a single center inception cohort of early rheumatoid arthritis patients
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
The analysis of prognostic factors in patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept